88 related articles for article (PubMed ID: 23803694)
1. NQO1 prevents radiation-induced aneuploidy by interacting with Aurora-A.
Park MT; Oh ET; Song MJ; Lee H; Choi EK; Park HJ
Carcinogenesis; 2013 Nov; 34(11):2470-85. PubMed ID: 23803694
[TBL] [Abstract][Full Text] [Related]
2. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
Garate M; Wani AA; Li G
Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
[TBL] [Abstract][Full Text] [Related]
3. Aurora a and B overexpression and centrosome amplification in early estrogen-induced tumor foci in the Syrian hamster kidney: implications for chromosomal instability, aneuploidy, and neoplasia.
Hontz AE; Li SA; Lingle WL; Negron V; Bruzek A; Salisbury JL; Li JJ
Cancer Res; 2007 Apr; 67(7):2957-63. PubMed ID: 17409401
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
[TBL] [Abstract][Full Text] [Related]
5. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Fagerholm R; Hofstetter B; Tommiska J; Aaltonen K; Vrtel R; Syrjäkoski K; Kallioniemi A; Kilpivaara O; Mannermaa A; Kosma VM; Uusitupa M; Eskelinen M; Kataja V; Aittomäki K; von Smitten K; Heikkilä P; Lukas J; Holli K; Bartkova J; Blomqvist C; Bartek J; Nevanlinna H
Nat Genet; 2008 Jul; 40(7):844-53. PubMed ID: 18511948
[TBL] [Abstract][Full Text] [Related]
7. Computational investigation of cancer-associated molecular mechanism in Aurora A (S155R) mutation.
Kumar A; Rajendran V; Sethumadhavan R; Purohit R
Cell Biochem Biophys; 2013 Jul; 66(3):787-96. PubMed ID: 23412841
[TBL] [Abstract][Full Text] [Related]
8. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
9. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells.
Lee SO; Chang YC; Whang K; Kim CH; Lee IS
Cardiovasc Res; 2007 Nov; 76(2):331-9. PubMed ID: 17669387
[TBL] [Abstract][Full Text] [Related]
10. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
11. Protection of hydroquinone-induced apoptosis by downregulation of Fau is mediated by NQO1.
Siew EL; Chan KM; Williams GT; Ross D; Inayat-Hussain SH
Free Radic Biol Med; 2012 Oct; 53(8):1616-24. PubMed ID: 22687461
[TBL] [Abstract][Full Text] [Related]
12. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.
Siemankowski LM; Morreale J; Butts BD; Briehl MM
Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079
[TBL] [Abstract][Full Text] [Related]
13. Aurora-A transcriptional silencing and vincristine treatment show a synergistic effect in human tumor cells.
Lentini L; Amato A; Schillaci T; Insalaco L; Di Leonardo A
Oncol Res; 2008; 17(3):115-25. PubMed ID: 18669163
[TBL] [Abstract][Full Text] [Related]
14. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1.
Moscovitz O; Tsvetkov P; Hazan N; Michaelevski I; Keisar H; Ben-Nissan G; Shaul Y; Sharon M
Mol Cell; 2012 Jul; 47(1):76-86. PubMed ID: 22793692
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
Tsvetkov P; Asher G; Reiss V; Shaul Y; Sachs L; Lotem J
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5535-40. PubMed ID: 15809436
[TBL] [Abstract][Full Text] [Related]
16. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
17. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.
Gerlach U; Kayser G; Walch A; Hopt U; Schulte-Mönting J; Werner M; Lassmann S
J Pathol; 2006 Mar; 208(4):462-72. PubMed ID: 16402339
[TBL] [Abstract][Full Text] [Related]
18. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S
Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714
[TBL] [Abstract][Full Text] [Related]
19. Induction of quinone oxidoreductase 1 enzyme by Rhazya stricta through Nrf2-dependent mechanism.
El Gendy MA; Ali BH; Michail K; Siraki AG; El-Kadi AO
J Ethnopharmacol; 2012 Nov; 144(2):416-24. PubMed ID: 23026305
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?
Giet R; Petretti C; Prigent C
Trends Cell Biol; 2005 May; 15(5):241-50. PubMed ID: 15866028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
